Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Study shows metastasizing cancer cells undergo molecular change during EMT

For the majority of cancer patients, it's not the primary tumor that is deadly, but the spread or "metastasis" of cancer cells from the primary tumor to secondary locations throughout the body that is the problem. That's why a major focus of contemporary cancer research is how to stop or fight metastasis.

14 Aug 2013

Proton therapy provides organ-sparing treatment option for children with neuroblastoma

Proton therapy, using high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma. For patients in a new study of advanced radiation treatment, proton therapy spared the liver and kidneys from unwanted radiation, while zeroing in on its target.

14 Aug 2013

Researchers discover the origin of HPV-related tonsillar cancer

American and European research shows an alarming increase in the rate of tonsillar cancer related to the human papilloma virus (HPV), a sexually transmitted virus. Experts suggest a similar trend has emerged in Canada, but it had yet to be confirmed through scientific analysis.

14 Aug 2013

RaySearch Laboratories announces first patient treated with RayStation

RaySearch Laboratories AB announces that the first patient in Australasia has been treated with a treatment plan created with RaySearch's treatment planning system RayStation®. The treatment was carried out at Auckland Radiation Oncology in Auckland, New Zealand.

From Elekta 13 Aug 2013

Study reports high survival rates for children with rare subtype of leukaemia

A pioneering genetic study means that children with a rare subtype of leukaemia have 75% less chance of their leukaemia recurring.

13 Aug 2013

Coalition with Innovative Life Sciences delivers best medicine in oncology for cancer patients

GenoSpace, PathGroup and the IP & Science business of Thomson Reuters today announced an innovative initiative to develop and deliver a best-in-class personalized medicine service in oncology, the result of which will enable physicians to make more precise therapeutic recommendations for cancer patients.

13 Aug 2013

Perrigo Company and Teva Pharmaceutical launch generic equivalent to temozolomide

Teva Pharmaceutical Industries Ltd. and Perrigo Company today announced the launch of the generic equivalent to Temodar (temozolomide).

13 Aug 2013

Scientist develop mathematical model that predicts how individuals respond to cancer treatment

Vittorio Cristini, PhD, uses the example of an airplane to explain what he does in cancer research. "Before calculus," he says, "people couldn't really design a plane that would fly. You can do it by trial and error, but it would probably take centuries." Dr. Cristini has a faster way to try to understand cancer treatment. Like airplane designers today, he uses a mathematical model.

13 Aug 2013

Websites to chronicle cancer experience reduce depression in women with breast cancer

Adults increasingly are conveying their personal experience with serious disease online, but do such chronicles help the authors or their audience? In the first known study of its kind, UCLA researchers have discovered that creating a personal website to chronicle the cancer experience and communicate with the author's interpersonal circle can reduce depressive symptoms, increase positive mood, and enhance appreciation for life in women diagnosed with breast cancer.

13 Aug 2013

Researchers identify first disease gene for idiopathic focal epilepsy in childhood

More than 50 million people worldwide have epilepsy, with a third of these being children. The most common forms of epilepsy in children occur without any apparent trigger and only affect certain regions of the brain.

12 Aug 2013

State highlights: Accusations of fraud or abuse in disabled, rehabilitation clinics in N.Y., Mich. and Calif.

Two and a half years ago, The New York Times published an article about abusive employees who worked for the state, detailing how few employees were fired, even after the state recommended that they lose their jobs, because of weaknesses in the arbitration process, the permissive attitude of state officials and the aggressive stance of public sector labor unions -- particularly the Civil Service Employees Association. Gov. Andrew M. Cuomo promised to change all this.

12 Aug 2013

ProMedica and Cleveland Clinic collaborate to develop health system affiliation

ProMedica and Cleveland Clinic have signed a Memorandum of Understanding to develop a health system affiliation that will better position both organizations to anticipate and proactively respond to the evolving healthcare landscape.

9 Aug 2013

Journey Forward creates tool to help cancer survivors initiate care planning with health care providers

Journey Forward, a leader in Survivorship Care Planning, is moving forward patient-centered care by enhancing its suite of free, award-winning survivorship care planning tools with My Care Plan.

9 Aug 2013

Eisai's investigational compound receives orphan drug designation for cutaneous t-cell lymphoma

Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.

9 Aug 2013

High mobility group (HMG) genes and cancer: an interview with Dr. Linda Resar, Johns Hopkins University School of Medicine

High mobility group A genes are highly expressed in all aggressive cancers studied to date. These genes encode the high mobility group A (HMGA) proteins. In other words, these genes provide the genetic “code” necessary to produce HMGA proteins.

8 Aug 2013

Janssen receives EC approval to use VELCADE as induction therapy in patients with multiple myeloma

Janssen-Cilag International NV announced today that the European Commission has approved the use of VELCADE (bortezomib) as induction therapy (a first therapeutic option) in combination with dexamethasone or thalidomide and dexamethasone. This licence extension will apply to adult patients with previously-untreated multiple myeloma who are eligible for high-dose chemotherapy with haematological stem cell transplantation.

8 Aug 2013

Standardizing care for penile cancer

Penile cancer is rare, with an average of 1,200 new cases per year in the United States, but it can be debilitating and lethal. Without evidenced-based treatment approaches, outcomes have varied widely. Philippe E. Spiess, M.D., an associate member in the Department of Genitourinary Oncology at Moffitt Cancer Center, presented new National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology to standardize care for penile cancer in an article that appeared in the July issue of the Journal of the National Comprehensive Cancer Network.

8 Aug 2013

NCI renews UCLA prostate SPORE grant

UCLA's Jonsson Comprehensive Cancer Center and the department of urology at the David Geffen School of Medicine at UCLA have been notified that their standing as a National Cancer Institute Specialized Program of Research Excellence site in prostate cancer has been renewed for another five years.

8 Aug 2013

Brain tumor cells in arrested development contribute to cell variety that protects cancer

A program that pushes immature cells to grow up and fulfill their destiny as useful, dedicated cells is short-circuited in the most common and deadly form of brain tumor, scientists at The University of Texas MD Anderson Cancer Center report this week in the Early Edition of the Proceedings of the National Academy of Sciences.

8 Aug 2013

Study shows tamoxifen prevents breast cancers in many women

The global study was led by University of Melbourne and the Peter MacCallum Cancer Centre and published in the Journal of Clinical Oncology today.

8 Aug 2013

Oncology News and Research

Further Reading

Study shows metastasizing cancer cells undergo molecular change during EMT

Proton therapy provides organ-sparing treatment option for children with neuroblastoma

Researchers discover the origin of HPV-related tonsillar cancer

RaySearch Laboratories announces first patient treated with RayStation

Study reports high survival rates for children with rare subtype of leukaemia

Coalition with Innovative Life Sciences delivers best medicine in oncology for cancer patients

Perrigo Company and Teva Pharmaceutical launch generic equivalent to temozolomide

Scientist develop mathematical model that predicts how individuals respond to cancer treatment

Websites to chronicle cancer experience reduce depression in women with breast cancer

Researchers identify first disease gene for idiopathic focal epilepsy in childhood

State highlights: Accusations of fraud or abuse in disabled, rehabilitation clinics in N.Y., Mich. and Calif.

ProMedica and Cleveland Clinic collaborate to develop health system affiliation

Journey Forward creates tool to help cancer survivors initiate care planning with health care providers

Eisai's investigational compound receives orphan drug designation for cutaneous t-cell lymphoma

High mobility group (HMG) genes and cancer: an interview with Dr. Linda Resar, Johns Hopkins University School of Medicine

Janssen receives EC approval to use VELCADE as induction therapy in patients with multiple myeloma

Standardizing care for penile cancer

NCI renews UCLA prostate SPORE grant

Brain tumor cells in arrested development contribute to cell variety that protects cancer

Study shows tamoxifen prevents breast cancers in many women

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News